• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Gene Therapy

Recent news which mentions Gene Therapy

< Previous 1 2 3 Next >
YouthBio Therapeutics Announces Significant Results from Joint Study with Dr. Ocampo Demonstrating Amelioration of Age-Related Cognitive Decline
August 06, 2024
Tags Partial Reprogramming Gene Therapy Medical
From PRLog
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers ALS NEWS WENA
Tags Benzinga Market News Pooja Rajkumari
From Benzinga
16-Minute Gene Therapy Restores Hearing To British Baby, A World First
May 13, 2024
Tags genetic engineering Pfizer Benzinga
From Benzinga
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
May 08, 2024
Tickers NEWS PFE
Tags Health Care General Biotech
From Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
Tickers BEAM LLY NEWS VERV
Tags Health Care BEAM VERV
From Benzinga
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
June 08, 2023
Tickers ALPMF ALPMY
Tags Benzinga ALPMY Market News
From Benzinga
FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
May 15, 2023
Tickers SRPT
Tags FDA Benzinga Market News
From Benzinga
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
Tickers BLUE CRSP VRTX
Tags General News Briefs
From Benzinga
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
April 07, 2023
Tickers LLY NVS RCKT
Tags News Interview NVS
From Benzinga
Tesla, Meta, Thermogenesis, Adobe, UiPath: Why These 5 Stocks Are Drawing Investors' Attention Today
March 15, 2023
Tickers ADBE CS META PATH
Tags Markets Top Stories THMO
From Benzinga
Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
November 03, 2022
Tickers RGNX
Tags Trading Ideas Benzinga Market News
From Benzinga
What Happened With Ocugen Shares During Wednesday's After-Hours Session
October 12, 2022
Tickers OCGN
Tags General why it's moving News
From Benzinga
Creative Biolabs Updates Service to Advance Development of Gene Delivery Systems
September 28, 2022
Tags gene therapy Biotechnology
From PRUnderground
This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
August 23, 2022
Tickers OCGN
Tags News Briefs Movers
From Benzinga
Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive
August 17, 2022
Tickers BLUE
Tags General why it's moving Briefs
From Benzinga
Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
August 12, 2022
Tickers FIXX
Tags FIXX Market News Benzinga
From Benzinga
This Penny Stock Touts Encouraging Long-Term Data For Hemophilia Gene Therapy
July 21, 2022
Tickers FRLN
Tags General Health Care Briefs
From Benzinga
Adverum Posts New Data From Wet AMD Gene Therapy Trial
July 15, 2022
Tickers ADVM
Tags Movers Briefs News
From Benzinga
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
July 06, 2022
Tickers RHHBF RHHBY RHHVF SRPT
Tags Market News Trading Ideas Benzinga
From Benzinga
MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial
June 28, 2022
Tickers JNJ MGTX
Tags JNJ General Briefs
From Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
June 27, 2022
Tickers ALPMF ALPMY
Tags FDA Benzinga ALPMY
From Benzinga
UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial
June 23, 2022
Tickers QURE
Tags News why it's moving Briefs
From Benzinga
BMO Capital Says Risk/Reward For This Gene Stock Assumes Clinical Success
June 17, 2022
Tickers BEAM
Tags Briefs News Price Target
From Benzinga
Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive
June 13, 2022
Tickers BLUE CRSP VRTX
Tags Market News Analyst Ratings Penny Stocks
From Benzinga
Mizuho Comments On UniQure's Upcoming Low-Dose Huntington's Gene Therapy Trial Data
June 13, 2022
Tickers QURE
Tags QURE Reiteration Analyst Color
From Benzinga
Mustang Bio Posts Encouraging Interim Data From Gene Therapy Trial In Immunodeficiency
May 19, 2022
Tickers MBIO
Tags General Movers MBIO
From Benzinga
Rocket Pharma's Gene Therapy Shows 100% Overall Survival In Immune Deficiency Disorder
May 19, 2022
Tickers RCKT
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study
May 18, 2022
Tickers AVRO
Tags Preclinical Phase General Health Care
From Benzinga
AVROBIO Shares Jumps On Encouraging Data From Early-Stage Gene Therapy Study
May 17, 2022
Tickers AVRO
Tags Movers News Briefs
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
Tickers ABEO AGTC AKTX AMPE
Tags ABEO ZEAL Large Cap
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap